Medical Care

Global Personalized Cell Therapy Market Research Report 2025

The global market for Personalized Cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.The personalized cell therapy is mainly developed for the treatment of high unmet need disease
North American market for Personalized Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Personalized Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Personalized Cell Therapy in Cardiovascular Diseases is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Personalized Cell Therapy include Novartis AG, Vericel Corporation, Bellicum Pharmaceuticals, MolMed SpA, Cytori Therapeutics Inc, Gilead Sciences, Inc, Celgene Corporation, Bluebird Bio, Aurora Biopharma Inc, Saneron CCEL Therapeutics，Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Personalized Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cell Therapy.
The Personalized Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Vericel Corporation
Bellicum Pharmaceuticals
MolMed SpA
Cytori Therapeutics Inc
Gilead Sciences, Inc
Celgene Corporation
Bluebird Bio
Aurora Biopharma Inc
Saneron CCEL Therapeutics，Inc
Kuur Therapeutics
MediGene AG
Sangamo Therapeutics
Segment by Type
By Cell Type
By Technique
Segment by Application
Cardiovascular Diseases
Neurological Disorders
Inflammatory Diseases
Diabetes
Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 By Cell Type
1.2.3 By Technique
1.3 Market by Application
1.3.1 Global Personalized Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Diseases
1.3.3 Neurological Disorders
1.3.4 Inflammatory Diseases
1.3.5 Diabetes
1.3.6 Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cell Therapy Market Perspective (2020-2031)
2.2 Global Personalized Cell Therapy Growth Trends by Region
2.2.1 Global Personalized Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Personalized Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Personalized Cell Therapy Market Dynamics
2.3.1 Personalized Cell Therapy Industry Trends
2.3.2 Personalized Cell Therapy Market Drivers
2.3.3 Personalized Cell Therapy Market Challenges
2.3.4 Personalized Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cell Therapy Players by Revenue
3.1.1 Global Top Personalized Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Personalized Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Personalized Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Cell Therapy Revenue
3.4 Global Personalized Cell Therapy Market Concentration Ratio
3.4.1 Global Personalized Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cell Therapy Revenue in 2024
3.5 Global Key Players of Personalized Cell Therapy Head office and Area Served
3.6 Global Key Players of Personalized Cell Therapy, Product and Application
3.7 Global Key Players of Personalized Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cell Therapy Breakdown Data by Type
4.1 Global Personalized Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Personalized Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Personalized Cell Therapy Breakdown Data by Application
5.1 Global Personalized Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Personalized Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Cell Therapy Market Size (2020-2031)
6.2 North America Personalized Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Cell Therapy Market Size by Country (2020-2025)
6.4 North America Personalized Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Cell Therapy Market Size (2020-2031)
7.2 Europe Personalized Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Personalized Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Personalized Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Cell Therapy Market Size (2020-2031)
9.2 Latin America Personalized Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Personalized Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Personalized Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Personalized Cell Therapy Introduction
11.1.4 Novartis AG Revenue in Personalized Cell Therapy Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Vericel Corporation
11.2.1 Vericel Corporation Company Details
11.2.2 Vericel Corporation Business Overview
11.2.3 Vericel Corporation Personalized Cell Therapy Introduction
11.2.4 Vericel Corporation Revenue in Personalized Cell Therapy Business (2020-2025)
11.2.5 Vericel Corporation Recent Development
11.3 Bellicum Pharmaceuticals
11.3.1 Bellicum Pharmaceuticals Company Details
11.3.2 Bellicum Pharmaceuticals Business Overview
11.3.3 Bellicum Pharmaceuticals Personalized Cell Therapy Introduction
11.3.4 Bellicum Pharmaceuticals Revenue in Personalized Cell Therapy Business (2020-2025)
11.3.5 Bellicum Pharmaceuticals Recent Development
11.4 MolMed SpA
11.4.1 MolMed SpA Company Details
11.4.2 MolMed SpA Business Overview
11.4.3 MolMed SpA Personalized Cell Therapy Introduction
11.4.4 MolMed SpA Revenue in Personalized Cell Therapy Business (2020-2025)
11.4.5 MolMed SpA Recent Development
11.5 Cytori Therapeutics Inc
11.5.1 Cytori Therapeutics Inc Company Details
11.5.2 Cytori Therapeutics Inc Business Overview
11.5.3 Cytori Therapeutics Inc Personalized Cell Therapy Introduction
11.5.4 Cytori Therapeutics Inc Revenue in Personalized Cell Therapy Business (2020-2025)
11.5.5 Cytori Therapeutics Inc Recent Development
11.6 Gilead Sciences, Inc
11.6.1 Gilead Sciences, Inc Company Details
11.6.2 Gilead Sciences, Inc Business Overview
11.6.3 Gilead Sciences, Inc Personalized Cell Therapy Introduction
11.6.4 Gilead Sciences, Inc Revenue in Personalized Cell Therapy Business (2020-2025)
11.6.5 Gilead Sciences, Inc Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Details
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Personalized Cell Therapy Introduction
11.7.4 Celgene Corporation Revenue in Personalized Cell Therapy Business (2020-2025)
11.7.5 Celgene Corporation Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Details
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Personalized Cell Therapy Introduction
11.8.4 Bluebird Bio Revenue in Personalized Cell Therapy Business (2020-2025)
11.8.5 Bluebird Bio Recent Development
11.9 Aurora Biopharma Inc
11.9.1 Aurora Biopharma Inc Company Details
11.9.2 Aurora Biopharma Inc Business Overview
11.9.3 Aurora Biopharma Inc Personalized Cell Therapy Introduction
11.9.4 Aurora Biopharma Inc Revenue in Personalized Cell Therapy Business (2020-2025)
11.9.5 Aurora Biopharma Inc Recent Development
11.10 Saneron CCEL Therapeutics，Inc
11.10.1 Saneron CCEL Therapeutics，Inc Company Details
11.10.2 Saneron CCEL Therapeutics，Inc Business Overview
11.10.3 Saneron CCEL Therapeutics，Inc Personalized Cell Therapy Introduction
11.10.4 Saneron CCEL Therapeutics，Inc Revenue in Personalized Cell Therapy Business (2020-2025)
11.10.5 Saneron CCEL Therapeutics，Inc Recent Development
11.11 Kuur Therapeutics
11.11.1 Kuur Therapeutics Company Details
11.11.2 Kuur Therapeutics Business Overview
11.11.3 Kuur Therapeutics Personalized Cell Therapy Introduction
11.11.4 Kuur Therapeutics Revenue in Personalized Cell Therapy Business (2020-2025)
11.11.5 Kuur Therapeutics Recent Development
11.12 MediGene AG
11.12.1 MediGene AG Company Details
11.12.2 MediGene AG Business Overview
11.12.3 MediGene AG Personalized Cell Therapy Introduction
11.12.4 MediGene AG Revenue in Personalized Cell Therapy Business (2020-2025)
11.12.5 MediGene AG Recent Development
11.13 Sangamo Therapeutics
11.13.1 Sangamo Therapeutics Company Details
11.13.2 Sangamo Therapeutics Business Overview
11.13.3 Sangamo Therapeutics Personalized Cell Therapy Introduction
11.13.4 Sangamo Therapeutics Revenue in Personalized Cell Therapy Business (2020-2025)
11.13.5 Sangamo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Personalized Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of By Cell Type
Table 3. Key Players of By Technique
Table 4. Global Personalized Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Personalized Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Personalized Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Personalized Cell Therapy Market Share by Region (2020-2025)
Table 8. Global Personalized Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Personalized Cell Therapy Market Share by Region (2026-2031)
Table 10. Personalized Cell Therapy Market Trends
Table 11. Personalized Cell Therapy Market Drivers
Table 12. Personalized Cell Therapy Market Challenges
Table 13. Personalized Cell Therapy Market Restraints
Table 14. Global Personalized Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Personalized Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top Personalized Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cell Therapy as of 2024)
Table 17. Ranking of Global Top Personalized Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Personalized Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Personalized Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Personalized Cell Therapy, Product and Application
Table 21. Global Key Players of Personalized Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Personalized Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Personalized Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Personalized Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Personalized Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Personalized Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Personalized Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Personalized Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Personalized Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Personalized Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Personalized Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Personalized Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Personalized Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Personalized Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Personalized Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Personalized Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Personalized Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Personalized Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Personalized Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Personalized Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Personalized Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Personalized Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Personalized Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Personalized Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis AG Company Details
Table 47. Novartis AG Business Overview
Table 48. Novartis AG Personalized Cell Therapy Product
Table 49. Novartis AG Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Novartis AG Recent Development
Table 51. Vericel Corporation Company Details
Table 52. Vericel Corporation Business Overview
Table 53. Vericel Corporation Personalized Cell Therapy Product
Table 54. Vericel Corporation Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Vericel Corporation Recent Development
Table 56. Bellicum Pharmaceuticals Company Details
Table 57. Bellicum Pharmaceuticals Business Overview
Table 58. Bellicum Pharmaceuticals Personalized Cell Therapy Product
Table 59. Bellicum Pharmaceuticals Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. Bellicum Pharmaceuticals Recent Development
Table 61. MolMed SpA Company Details
Table 62. MolMed SpA Business Overview
Table 63. MolMed SpA Personalized Cell Therapy Product
Table 64. MolMed SpA Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. MolMed SpA Recent Development
Table 66. Cytori Therapeutics Inc Company Details
Table 67. Cytori Therapeutics Inc Business Overview
Table 68. Cytori Therapeutics Inc Personalized Cell Therapy Product
Table 69. Cytori Therapeutics Inc Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Cytori Therapeutics Inc Recent Development
Table 71. Gilead Sciences, Inc Company Details
Table 72. Gilead Sciences, Inc Business Overview
Table 73. Gilead Sciences, Inc Personalized Cell Therapy Product
Table 74. Gilead Sciences, Inc Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Gilead Sciences, Inc Recent Development
Table 76. Celgene Corporation Company Details
Table 77. Celgene Corporation Business Overview
Table 78. Celgene Corporation Personalized Cell Therapy Product
Table 79. Celgene Corporation Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. Celgene Corporation Recent Development
Table 81. Bluebird Bio Company Details
Table 82. Bluebird Bio Business Overview
Table 83. Bluebird Bio Personalized Cell Therapy Product
Table 84. Bluebird Bio Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Bluebird Bio Recent Development
Table 86. Aurora Biopharma Inc Company Details
Table 87. Aurora Biopharma Inc Business Overview
Table 88. Aurora Biopharma Inc Personalized Cell Therapy Product
Table 89. Aurora Biopharma Inc Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. Aurora Biopharma Inc Recent Development
Table 91. Saneron CCEL Therapeutics，Inc Company Details
Table 92. Saneron CCEL Therapeutics，Inc Business Overview
Table 93. Saneron CCEL Therapeutics，Inc Personalized Cell Therapy Product
Table 94. Saneron CCEL Therapeutics，Inc Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. Saneron CCEL Therapeutics，Inc Recent Development
Table 96. Kuur Therapeutics Company Details
Table 97. Kuur Therapeutics Business Overview
Table 98. Kuur Therapeutics Personalized Cell Therapy Product
Table 99. Kuur Therapeutics Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 100. Kuur Therapeutics Recent Development
Table 101. MediGene AG Company Details
Table 102. MediGene AG Business Overview
Table 103. MediGene AG Personalized Cell Therapy Product
Table 104. MediGene AG Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 105. MediGene AG Recent Development
Table 106. Sangamo Therapeutics Company Details
Table 107. Sangamo Therapeutics Business Overview
Table 108. Sangamo Therapeutics Personalized Cell Therapy Product
Table 109. Sangamo Therapeutics Revenue in Personalized Cell Therapy Business (2020-2025) & (US$ Million)
Table 110. Sangamo Therapeutics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report


List of Figures
Figure 1. Personalized Cell Therapy Picture
Figure 2. Global Personalized Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Personalized Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. By Cell Type Features
Figure 5. By Technique Features
Figure 6. Global Personalized Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Personalized Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Neurological Disorders Case Studies
Figure 10. Inflammatory Diseases Case Studies
Figure 11. Diabetes Case Studies
Figure 12. Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Personalized Cell Therapy Report Years Considered
Figure 15. Global Personalized Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Personalized Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Personalized Cell Therapy Market Share by Region: 2024 VS 2031
Figure 18. Global Personalized Cell Therapy Market Share by Players in 2024
Figure 19. Global Top Personalized Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cell Therapy as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Personalized Cell Therapy Revenue in 2024
Figure 21. North America Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Personalized Cell Therapy Market Share by Country (2020-2031)
Figure 23. United States Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Personalized Cell Therapy Market Share by Country (2020-2031)
Figure 27. Germany Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Personalized Cell Therapy Market Share by Region (2020-2031)
Figure 35. China Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Personalized Cell Therapy Market Share by Country (2020-2031)
Figure 43. Mexico Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Personalized Cell Therapy Market Share by Country (2020-2031)
Figure 47. Turkey Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Personalized Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Novartis AG Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 51. Vericel Corporation Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 52. Bellicum Pharmaceuticals Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 53. MolMed SpA Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 54. Cytori Therapeutics Inc Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 55. Gilead Sciences, Inc Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 56. Celgene Corporation Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 57. Bluebird Bio Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 58. Aurora Biopharma Inc Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 59. Saneron CCEL Therapeutics，Inc Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 60. Kuur Therapeutics Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 61. MediGene AG Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 62. Sangamo Therapeutics Revenue Growth Rate in Personalized Cell Therapy Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies